Literature DB >> 221687

Single daily dose prednisone therapy.

H F Klinefelter, W L Winkenwerder, T Bledsoe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 221687

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy.

Authors:  Panteleimon D Mavroudis; John van den Anker; Laurie S Conklin; Jesse M Damsker; Eric P Hoffman; Kanneboyina Nagaraju; Paula R Clemens; William J Jusko
Journal:  J Clin Pharmacol       Date:  2019-02-11       Impact factor: 3.126

2.  Influence of the time of administration of dexamethasone 0.25 mg on cortisol secretion in normal humans.

Authors:  P Schulz; C Costa; J Widmer; P Dick
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Adrenal corticosteroids in the treatment of asthma.

Authors:  S C Siegel
Journal:  Clin Rev Allergy       Date:  1983-03

4.  Time of day of prednisolone administration in rheumatoid arthritis.

Authors:  I C Kowanko; R Pownall; M S Knapp; A J Swannell; P G Mahoney
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

5.  The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis.

Authors:  M De Silva; A Binder; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

6.  Bedtime single-dose prednisolone in clinically stable rheumatoid arthritis patients.

Authors:  Mohammad Bagher Owlia; Owlia Mohammad Bagher; Golbarg Mehrpoor; Mehrpoor Golbarg; Moneyreh Modares Mosadegh; Modares Mosadegh Moneyreh
Journal:  ISRN Pharmacol       Date:  2012-03-05

Review 7.  Circadian rhythms in rheumatology--a glucocorticoid perspective.

Authors:  Cornelia M Spies; Rainer H Straub; Maurizio Cutolo; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2014-11-13       Impact factor: 5.156

Review 8.  Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.

Authors:  Marco Krasselt; Christoph Baerwald
Journal:  Drug Des Devel Ther       Date:  2016-03-08       Impact factor: 4.162
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.